Pramipexole/Aprepitant

N/A

Report date: 2025/06/09 20:00:12

Base Information

Drug NamePramipexole/Aprepitant
Drug Alias NameALTO-208CTC 413CTC-413
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonistsDopamine D4 receptor agonistsDopamine D2 receptor agonists +[4] 
TargetsDopamine D2 receptorDopamine D4 receptorDopamine D3 receptor +[4] 
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Pramipexole Dihydrochloride HydrateAprepitant
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChase Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesAlto Neuroscience IncChase Therapeutics Co
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A